Who will Control Drug Prices: The President, Congress, States, or Big Pharma?

By: Jessica Johnson High-profile stories of EpiPen prices increasing from roughly $104 to $609 in less than a decade[1] and stories of patients skipping insulin doses to stretch supplies between paychecks have dominated the American news cycle in recent years.[2]  While these stories are breaking headlines, these issues are far from new.[3]  Nearly 60 years […]

Violating Settlement Agreement with SEC Does Not Bode Well for Elon Musk

By: Jonathan Huie In response to Elon Musk’s tweets on February 19, 2019,[1] the Securities and Exchange Commission (hereinafter “SEC”) swiftly filed a motion asking a federal judge to hold Musk in contempt for violating a settlement agreement.[2]  The SEC previously charged Musk with securities fraud in September of 2018 for a series of misleading […]

Multilevel Marketing and Social Media Recruitment

By: Caroline M. Whitlock Multilevel marketing (hereinafter “MLM”) companies are sales organizations that compensate independent consultants based on the sales and recruitment of other consultants.[1]  Avon, Herbalife, and LulaRoe are big name companies that sell products through multilevel marketing.[2]  MLMs involve “direct selling”-an industry which is vastly unregulated and leaves ample room for deceiving new […]

Killer Corporations Don’t go to Jail

By: Robert Lackey On December 3, 1984, Union Carbide’s Methyl isocyanate (hereinafter “MIC”), a poisonous compound with manifold applications in manufacturing in Bhopal, India, exploded and released forty tons of its product into the local atmosphere, killing over 2,500 people and injuring another 200,000.[1]  Union Carbide’s main consequence from this disaster was a settlement to […]

Potential Impact of President Trump’s Artificial Intelligence Executive Order

By: Chris Katsantonis On February 11, 2019, President Trump signed an Executive Order (hereinafter “Order”) on “Maintaining American Leadership on Artificial Intelligence.”[1] The Order is not much of a surprise considering China’s recent push to become the leader in Artificial Intelligence (“AI”).[2]  The Order aims to encourage advancements in technology, international and industry collaboration with […]